Bisacodyl Delayed Release Tablets USP 5 mg- Pink

Manufacturer
Apnar Pharma LP | Apnar Pharma Private Limited
Effective date
2022-11-04
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:47:28

Label at a glance#

ProductBisacodyl
Active ingredientBISACODYL
Label structure12 sections

Boxed warning

Caution: Do not use if imprinted seal under cap is broken or missing.

Storage and handling

Other Information store at 15º-30ºC (59º - 86º F).

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each tablet)

Bisacodyl (USP) 5 mg

OTC - PURPOSE SECTION

Purpose

Stimulant laxative

INDICATIONS & USAGE SECTION

​Uses

  • for relief of occasional constipation and irregularity
  • this product generally produces bowel movement in 6 to 12 hours

WARNINGS SECTION

Warnings

Do not use

  • if you cannot swallow without chewing

Ask a doctor before use if you have:

  • stomach pain, nausea, or vomiting
  • noticed a sudden change in bowel habits that lasts more than 2 weeks

When using this product

  • it may cause stomach discomfort, faintness and cramps
  • do not chew or crush tablets(s)
  • do not use within 1 hour after taking antacid or milk

Stop use and ask a doctor if

  • you have rectal bleeding or fail to have a bowel movement after using this product. These could be signs of a serious condition.
  • you need to use a laxative for more than 1 week

If pregnant or breast-feeding,

ask a health care professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

DOSAGE & ADMINISTRATION SECTION

Directions

  • take with glass of water
  • adult and children 12 years of age and over- 1 to 3 tablets in a single daily dose
  • children 6 to under 12 years of age- 1 tablet in a single daily dose
  • children under 6 years of age- ask a doctor

STORAGE AND HANDLING SECTION

Other Information

  • store at 15º-30ºC (59º - 86º F).

INACTIVE INGREDIENT SECTION

Inactive ingredients

Lactose monohydrate, Anhydrous lactose, Pregelatinized starch, Magnesium stearate, Hypromellose, Triacetin, Talc, Methacrylic acid-ethyl acrylate copolymer (1:1) Type-A, Titanium dioxide, Triethyl citrate, D&C red no. 27, Colloidal anhydrous silica, Sodium bicarbonate, Sodium lauryl sulfate, FD&C blue no. 1, Carboxymethyl cellulose sodium, Maltodextrin, Dextrose monohydrate, Lecithin Soya.

OTC - QUESTIONS SECTION

Questions or comments?

  • 1-855-642-2594

SPL UNCLASSIFIED SECTION

Distributed By:

APNAR PHARMA LP

CHINO, CA, 91710

Rev.: 07/2022

Compare to Dulcolax Pink ®

active ingredient*

*This product is not maufactured or distributed by Boehringer Ingelheim Pharmaceuticals, Inc., owner of the registered trademark of Dulcolax Pink ®

BOXED WARNING SECTION

Caution: Do not use if imprinted seal under cap is broken or missing.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 24689-129-02

Bisacodyl Delayed Release Tablets USP

5 mg- Pink

Stimulant Laxative

20 Tablets

NDC 24689-129-02 Bisacodyl Delayed Release Tablets USP 5 mg- Pink 20 Tablets 300072NDC 24689-129-02 Bisacodyl Delayed Release Tablets USP 5 mg- Pink 20 Tablets 300072

NDC 24689-129-03

Bisacodyl Delayed Release Tablets USP

5 mg- Pink

Stimulant Laxative

100 Tablets

Bisacodyl DR Tablets - 5 mg -100s count labelBisacodyl DR Tablets - 5 mg -100s count label

NDC 24689-129-04

Bisacodyl Delayed Release Tablets USP

5 mg- Pink

Stimulant Laxative

250 Tablets

Bisacodyl DR Tablets - 5 mg -250s count labelBisacodyl DR Tablets - 5 mg -250s count label

NDC 24689-129-05

Bisacodyl Delayed Release Tablets USP

5 mg- Pink

Stimulant Laxative

500 Tablets

Bisacodyl DR Tablets - 5 mg -500s count labelBisacodyl DR Tablets - 5 mg -500s count label

FDA-Initiated Inactive NDC Indexing#

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
24689-129-02EA - Each24689-129d24bdef5-ae1b-49be-88a6-edcc20744c5a12023-04-07
24689-129-03EA - Each24689-1294f164bea-54d0-462e-a404-856b61008cef12023-04-07
24689-129-05EA - Each24689-1290dd342b2-74b9-4cc2-a66e-c1523f4cce9812023-03-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
24689-12924689-129-02, 24689-129-03, 24689-129-04, 24689-129-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
45d30503-3fa6-fe18-e063-6394a90a0d63ec9edf75-b9cc-0b99-e053-2995a90a391f2025-12-13Boxed warning, WarningsExact identifier
spl set id: ec9edf75-b9cc-0b99-e053-2995a90a391f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.